[
  {
    "ts": null,
    "headline": "Will Thermo Fisher’s (TMO) CFO Transition Reshape Its Succession Strategy and Management Outlook?",
    "summary": "Thermo Fisher Scientific recently presented at the Morgan Stanley Global Healthcare Conference and announced that CFO Stephen Williamson will retire in March 2026, with James R. Meyer named as his successor, while the CEO sold US$200,000 in shares under a pre-arranged plan. These leadership changes and executive share sales come amid shifting analyst sentiment and highlight the importance of management continuity during a period of industry transformation and investor attention to succession...",
    "url": "https://finnhub.io/api/news?id=855c241446f5ddaad684c90c10add011649d2aa0b58b33b6522c430804dc4ad4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757770797,
      "headline": "Will Thermo Fisher’s (TMO) CFO Transition Reshape Its Succession Strategy and Management Outlook?",
      "id": 136736055,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher Scientific recently presented at the Morgan Stanley Global Healthcare Conference and announced that CFO Stephen Williamson will retire in March 2026, with James R. Meyer named as his successor, while the CEO sold US$200,000 in shares under a pre-arranged plan. These leadership changes and executive share sales come amid shifting analyst sentiment and highlight the importance of management continuity during a period of industry transformation and investor attention to succession...",
      "url": "https://finnhub.io/api/news?id=855c241446f5ddaad684c90c10add011649d2aa0b58b33b6522c430804dc4ad4"
    }
  }
]